Imatinib mimics physiological response to produce antimicrobial effectsThe anti-cancer agent imatinib at very low doses mimics a physiological innate response to infection in the bone marrow, research shows.…
High doses of ibuprofen increase cardiovascular risk, EMA warns The European Medicines Agency has confirmed that high doses of ibuprofen and related molecule dexibuprofen carry a small increased risk of cardiovascular diseases.…
University of Sussex to offer pharmacy degrees from 2016The University of Sussex is to offer Master of Pharmacy degrees from 2016, pending accreditation of its course by the General Pharmaceutical Council.…
Mixing medicines: how to ensure patient safety Incompatibility poses a constant risk when mixing medicines but it can be avoided by understanding the chemical reactions taking place.…
Walgreens Boots Alliance announces surge in earningsThe newly-formed multinational pharmacy business Walgreens Boots Alliance has announced a surge in earnings and planned closures for 200 US pharmacies.…
Xylitol may not protect teeth from decay Cochrane reviewers have found little or no good-quality evidence to prove xylitol has a protective effect against tooth decay.…
Low doses of sequential antibiotics could treat infections, study finds Sequential therapy with two synergistic antibiotics over a period of 96 hours cleared bacterial infection in an in vitro treatment model of Escherichia coli.…
Parliament approves changes to regulations governing controlled drugsThe UK Parliament has approved a raft of amendments to the Misuse of Drugs Regulations 2001 that will come into force over the next few months.…
Pharmacy educator becomes new chief pharmaceutical officer for Scotland Rose Marie Parr has been appointed as the new chief pharmaceutical officer for Scotland, succeeding Bill Scott.…
Researchers create personalised vaccines for patients with advanced melanoma A study has revealed that targeting patient-specific markers in advanced melanoma tumours effectively triggers an immune response.…
